natalizumab
nzm
human
monoclon
antibodi
integrin
use
treat
patient
relapsingremit
multipl
sclerosi
ms
case
persist
neutral
antidrug
antibodi
ada
induc
lead
therapi
discontinu
understand
basi
ada
respons
mechan
adamedi
neutral
perform
indepth
analysi
b
cell
respons
two
patient
character
larg
panel
nzmspecif
monoclon
antibodi
found
patient
respons
polyclon
target
differ
epitop
nzm
idiotyp
neutral
activ
acquir
somat
mutat
correl
slow
dissoci
rate
find
support
structur
data
interestingli
patient
analysi
cell
respons
combin
mass
spectrometrybas
peptidom
reveal
singl
immunodomin
cell
epitop
span
region
nzm
light
chain
moreov
version
nzm
recogn
cell
retain
bind
integrin
collect
integr
analysi
identifi
basi
tb
collabor
lead
adamedi
therapeut
resist
delin
approach
design
novel
deimmun
antibodi
autoimmun
diseas
cancer
treatment
therapeut
use
monoclon
antibodi
biopharmaceut
product
result
immun
respons
drug
case
affect
efficaci
due
product
neutral
ada
sever
clinic
studi
measur
ada
level
sera
select
cohort
patient
conclud
antibodi
respons
lead
drug
neutral
howev
explan
heterogen
respons
integr
character
b
cell
respons
drug
still
miss
studi
isol
nzmspecif
b
cell
clone
memori
cell
two
ms
patient
hypersensit
reaction
follow
drug
infus
develop
high
titer
ada
supplementari
tabl
supplementari
fig
identifi
nzmspecif
antibodi
screen
supernat
immort
b
cell
isol
antinzm
monoclon
antibodi
patient
b
respect
tabl
sixti
percent
antibodi
patient
potent
inhibit
bind
nzm
integrin
surfac
cell
valu
ngml
defin
nab
neutral
antibodi
remain
show
reduc
inhibitori
capac
valu
ngml
defin
bab
bind
antibodi
fig
supplementari
tabl
interestingli
patient
b
develop
nonneutr
bab
find
may
relat
lower
number
nzm
infus
receiv
antibodi
isol
mostli
use
differ
v
j
gene
show
moder
level
somat
mutat
fig
nab
patient
carri
high
load
replac
mutat
complementari
determin
region
cdr
consist
antigendriven
select
fig
bab
patient
carri
replac
mutat
cdr
antibodi
fine
specif
test
use
nzm
variant
gener
swap
hypervari
cdr
loop
counterpart
human
scaffold
antibodi
use
nzm
human
extend
data
fig
antibodi
recogn
epitop
compris
one
six
nzm
cdr
preferenti
recognit
heavi
chain
cdr
fig
extend
data
fig
find
demonstr
nzm
induc
neutral
polyclon
antiidiotyp
antibodi
respons
target
multipl
epitop
locat
primarili
heavi
chain
cdr
differ
neutral
activ
antinzm
antibodi
isol
may
due
bind
distinct
epitop
altern
differ
affin
kinet
bind
compar
capac
bind
nzm
cdr
swap
variant
bab
nab
cluster
separ
extend
data
fig
indic
differ
relat
epitop
specif
howev
bab
nab
show
differ
bind
kinet
assess
surfac
plasmon
reson
spr
particular
associ
constant
k
compar
nab
show
lower
dissoci
constant
k
significantli
correl
nzm
neutral
abil
fig
supplementari
tabl
role
somat
mutat
address
compar
antibodi
unmut
common
ancestor
uca
three
four
bab
test
uca
low
bind
affin
nzm
increas
somat
mutat
contrast
two
three
nab
test
uca
show
alreadi
high
affin
requir
somat
mutat
gain
full
neutral
activ
fig
collect
find
indic
critic
role
somat
mutat
gener
highaffin
antibodi
highlight
import
dissoci
rate
ada
neutral
activ
next
determin
crystal
structur
bab
nab
complex
nzm
resolut
structur
reveal
antibodi
interact
surfac
area
nzm
engag
molecul
differ
orient
fig
supplementari
tabl
recogn
residu
nzm
cdr
respect
mostli
locat
heavi
chain
find
consist
cdr
swap
variant
specif
fig
particular
residu
recogn
antibodi
highlight
potenti
immunodomin
bcell
epitop
nzm
contact
surfac
area
nzm
although
main
interact
occur
two
separ
contact
point
leav
empti
space
two
interfac
fig
extend
data
fig
contrast
contact
surfac
area
nzm
interact
much
tighter
deeper
residu
contact
contigu
surfac
complementar
could
account
slower
dissoci
rate
nzm
fig
extend
data
fig
importantli
nzm
surfac
area
engag
overlap
area
engag
integrin
share
residu
fig
antibodi
occlud
integrin
bind
site
neither
provid
molecular
mimicri
integrin
exhibit
differ
bind
orient
extend
data
fig
togeth
function
data
structur
data
suggest
differ
bab
nab
explain
fine
epitop
specif
rather
strength
fit
interact
nzm
gener
neutral
ada
somat
mutat
consist
affin
matur
driven
cell
target
nonself
region
nzm
idiotyp
address
hypothesi
character
specif
tcell
respons
stimul
cfselabel
memori
cell
patient
overlap
peptid
cover
variabl
region
nzm
extend
data
fig
clone
activ
cfse
low
cell
result
isol
sever
nzmreactiv
cell
clone
patient
patient
b
fig
cell
receptor
tcr
sequenc
reveal
presenc
least
distinct
cell
clonotyp
patient
b
respect
fig
supplementari
tabl
strikingli
cell
clone
patient
recogn
two
overlap
peptid
span
region
compris
end
framework
region
nzm
light
chain
gkaprllihytsalqpgi
name
nzmlc
fig
note
cell
recognit
nzmlc
restrict
patient
patient
b
extend
data
fig
supplementari
tabl
taken
togeth
find
suggest
patient
singl
cell
epitop
nzm
molecul
induc
hladrrestrict
tcell
respons
suffici
sustain
strong
polyclon
b
cell
respons
nzm
idiotyp
investig
mechan
lead
present
nzm
cell
epitop
puls
nzmspecif
b
cell
clone
nzm
identifi
natur
process
mhciibound
peptid
mass
spectrometrybas
peptidom
three
set
nest
peptid
map
variabl
region
nzm
identifi
fig
supplementari
tabl
two
set
cover
heavi
chain
region
human
germlin
configur
therefor
expect
induc
immun
respons
notion
consist
failur
isol
specif
cell
clone
remark
third
set
peptid
map
region
nzm
light
chain
consensu
tpgkaprllihytsalqpgipsr
span
immunodomin
nzmlc
epitop
gkaprllihytsalqpgi
recogn
nzmreactiv
cell
clone
fig
supplementari
tabl
netmhciipan
algorithm
appli
predict
bind
hladr
allel
carri
two
patient
identifi
three
peptid
well
sever
peptid
map
cdr
fr
nzm
extend
data
fig
addit
algorithm
predict
bind
nzmlc
epitop
refer
panel
nine
allel
extend
data
fig
suggest
potenti
immunodomin
also
individu
divers
hla
background
collect
find
demonstr
one
potenti
immunogen
peptid
encod
six
cdr
nzm
natur
present
cell
epitop
abl
gener
polyclon
tcell
respons
identif
immunodomin
nzmlc
epitop
prompt
us
use
structureguid
design
engin
deimmun
version
nzm
first
identifi
residu
nzm
light
chain
engag
integrin
bind
model
differ
mutant
constraint
preserv
conform
specif
nzm
four
nzm
variant
retain
experiment
test
valid
togeth
fifth
variant
light
chain
revert
germlin
sequenc
human
antibodi
scaffold
fig
two
variant
retain
bind
integrin
show
partial
loss
bind
consider
reduc
case
fig
remark
none
five
nzm
variant
abl
trigger
prolifer
cell
clone
specif
natur
present
nzmlc
peptid
fig
find
consist
either
absenc
tcr
crossreact
reduc
bind
class
ii
molecul
predict
bind
refer
set
nine
allel
well
allel
patient
show
reduct
predict
bind
affin
peptid
compar
origin
nzm
peptid
fig
extend
data
fig
result
provid
two
deimmun
version
nzm
test
vivo
studi
integr
first
time
clonal
analysi
b
cell
repertoir
mass
spectrometrybas
peptidom
identifi
factor
underpin
neutral
antibodi
respons
human
therapeut
antibodi
larg
number
monoclon
antibodi
isol
recogn
multipl
epitop
span
differ
nzm
cdr
therefor
repres
classic
antiidiotyp
antibodi
rather
intern
imag
antigen
interestingli
neutral
antibodi
show
highlevel
replac
mutat
cdr
low
dissoci
rate
suggest
b
cell
select
driven
decreas
k
rather
increas
k
highli
divers
antiidiotyp
respons
consist
presenc
multipl
b
cell
epitop
recogn
b
cell
contrast
cell
respons
larg
limit
singl
epitop
map
region
nzm
light
chain
find
highlight
merit
human
technolog
limit
cell
immunogen
therapeut
antibodi
sinc
chimer
antibodi
found
elicit
cell
respons
multipl
epitop
fr
cdr
heavi
light
chain
expect
residu
immunogen
primarili
cdr
region
still
limit
hla
restrict
process
antigenpres
cell
previou
studi
report
posit
associ
nzmrelat
hypersensit
reaction
allel
investig
cell
respons
find
nzmlc
peptid
natur
present
context
allel
two
patient
togeth
predict
bind
differ
allel
includ
suggest
peptid
major
sourc
cell
help
drive
antiidiotyp
b
cell
respons
nzm
may
explain
high
frequenc
ms
patient
produc
ada
nzm
offer
possibl
deimmun
drug
safe
treatment
structuredguid
mutagenesi
experiment
test
suggest
littl
amend
three
residu
nzm
light
chain
may
suffici
remov
immunogen
cell
epitop
without
interf
interact
nzm
target
collect
result
demonstr
integr
peptidom
structur
data
silico
predict
dissect
specif
b
cell
respons
repres
power
approach
defin
immunogen
landscap
therapeut
antibodi
guid
deimmun
strategi
nextgener
biolog
therapeut
autoimmun
cancer
diseas
current
use
fulli
human
antibodi
includ
checkpoint
inhibitor
may
also
benefit
deimmun
strategi
reciproc
approach
could
use
improv
immunogen
vaccin
engin
domin
cell
epitop
drive
neutral
antibodi
respons
blood
sampl
collect
two
ms
patient
b
hypersensit
reaction
follow
infus
nzm
develop
high
titer
ada
patient
treat
nzm
univers
hospit
neurolog
innsbruck
austria
patient
b
treat
mondino
foundat
pavia
itali
patient
provid
written
inform
consent
studi
studi
approv
ethic
committe
innsbruck
pavia
blood
sampl
process
obtain
serum
peripher
blood
mononuclear
cell
pbmc
serum
prepar
whole
blood
collect
vacutain
tube
bd
bioscienc
contain
clot
activ
kept
room
temperatur
clot
form
tube
centrifug
min
serum
fraction
store
pbmc
isol
whole
blood
ficol
densiti
gradient
centrifug
resuspend
freez
medium
longterm
storag
liquid
nitrogen
variant
nzm
human
fc
replac
murin
counterpart
nzmmfc
produc
molecular
clone
use
elisa
fac
assay
avoid
reactiv
secondari
antihuman
antibodi
briefli
synthet
gene
express
nzm
heavi
chain
light
chain
variabl
region
kegg
drug
databas
entri
produc
genscript
sublcon
vector
express
chimer
human
heavi
chain
mfc
human
respect
chain
express
follow
transient
transfect
vector
cell
thermofish
scientif
use
polyethylenimin
cell
line
routin
test
mycoplasma
contamin
nzm
cdr
swap
variant
design
align
sequenc
nzm
human
antibodi
rei
use
human
genbank
access
number
synthet
genscript
subclon
mfc
vector
nzm
deimmun
variant
synthet
genscript
subclon
vector
express
full
human
antibodi
purifi
protein
protein
g
chromatographi
ge
healthcar
concentr
amicon
ultra
filter
unit
millipor
spr
massspectrometri
cell
experi
nzm
igg
purifi
drug
solut
infus
biogen
total
igg
quantifi
pierc
bca
protein
assay
thermofisch
monocyt
isol
pbmc
posit
select
use
magnet
microbead
miltenyi
biotech
irradi
pbmcfeeder
cell
previous
describ
two
week
post
immort
cultur
supernat
test
elisa
bind
nzmmfc
well
control
antibodi
irrelev
specif
b
cell
cultur
test
posit
nzmmfc
isol
expand
cdna
synthes
select
b
cell
cultur
vh
vl
gene
sequenc
previous
describ
gene
encod
vh
vl
number
somat
mutat
determin
analyz
homolog
gene
encod
vh
vl
sequenc
monoclon
antibodi
known
gene
encod
human
v
j
region
present
intern
immunogenet
inform
system
imgt
databas
version
antibodycod
sequenc
amplifi
sequenc
primer
specif
v
j
region
given
antibodi
sequenc
unmut
common
ancestor
uca
vhand
vlcode
gene
construct
use
imgtvquest
synthet
genscript
calcul
frequenc
mutat
entir
sequenc
heavi
chain
variabl
region
compar
germlin
sequenc
identifi
replac
r
silent
mutat
select
strength
estim
use
baselin
framework
compar
observ
frequenc
replac
silent
mutat
expect
one
calcul
done
use
calcbaselin
groupbaselin
function
shazam
version
sequenc
encod
antibodi
heavi
light
chain
clone
vector
express
human
chain
express
follow
transient
transfect
vector
cell
describ
select
antibodi
also
express
antigenbind
fragment
xray
crystallographi
analysi
total
igg
quantifi
use
maxisorp
plate
nunc
coat
goat
antihuman
igg
southernbiotech
cat
plate
block
pb
bsa
incub
titrat
monoclon
antibodi
use
certifi
refer
materi
sigmaaldrich
standard
plate
wash
incub
alkalin
phosphatas
ap
conjug
goat
antihuman
igg
southern
biotech
cat
substrat
paranitrophenyl
phosphat
pnpp
sigma
ad
plate
read
wavelength
nm
determin
optic
densiti
od
valu
test
specif
antibodi
bind
elisa
plate
coat
nzmmfc
control
antibodi
test
nonspecif
bind
plate
block
pb
bsa
incub
titrat
sera
monoclon
antibodi
follow
apconjug
goat
antihuman
igg
fragment
specif
antibodi
jackson
immunoresearch
cat
goat
antihuman
serum
iga
chain
specif
jackson
immunoresearch
cat
goat
antihuman
igm
fragment
specif
jackson
immunoresearch
cat
dissoci
assay
sampl
supplement
volvol
alkalin
dissoci
buffer
triton
ethanolamin
nacl
ph
one
minut
end
incub
test
antibodi
bind
nzm
cdr
swap
variant
elisa
plate
coat
goat
antimous
igg
human
adsorb
southern
biotech
cat
block
pb
bsa
wash
plate
incub
nzm
cdr
swap
variant
follow
monoclon
antibodi
concentr
apconjug
goat
antihuman
igg
fragment
specif
antibodi
heat
map
pattern
antibodi
bind
nzm
cdr
swap
variant
comput
use
default
cluster
paramet
function
gplot
packag
r
euclidean
metric
complet
aggreg
method
select
studi
kinet
interact
nzmspecif
monoclon
ada
nzm
igg
nm
stabil
mm
acet
buffer
ph
immobil
onto
edcnh
pre
xray
crystallographi
structureguid
deimmun
nzm
antibodi
produc
antigenbind
fragment
purifi
imac
hitraptm
imac
hp
ge
healthcar
stabl
complex
prepar
dpb
buffer
pb
dulbecco
gibco
molar
ratio
purifi
sizeexclus
chromatographi
superdex
ge
healthcar
concentr
mgml
crystal
grown
vapor
diffus
well
solut
contain
sodium
malon
ph
k
mm
nacl
mpd
mm
me
ph
typic
appear
within
week
crystal
flash
frozen
xray
data
collect
european
synchrotron
radiat
facil
beamlin
grenobl
use
softwar
data
collect
process
statist
outlin
supplementari
tabl
structur
solut
perform
molecular
replac
use
molrep
version
suit
version
crystallograph
refin
carri
use
buster
version
shape
correl
statist
sc
protein
interfac
calcul
superimposit
perform
use
structur
integrin
complex
refer
http
wwwrcsborg
surfac
area
calcul
base
van
der
waal
surfac
atom
nzm
lie
distanc
atom
deimmun
nzm
light
chain
antibodi
model
mutat
residu
posit
distanc
observ
structur
affect
conform
antibodi
cdr
region
nonexhaust
search
perform
number
potenti
mutat
select
mutagenesi
cell
cultur
rpmi
medium
supplement
mm
glutamin
vv
nonessenti
amino
acid
vv
sodium
pyruv
penicillin
uml
streptomycin
invitrogen
heatinactiv
human
serum
swiss
red
cross
sort
memori
cell
label
carboxyfluorescein
diacet
succinimidyl
ester
cfse
thermofish
cultur
ratio
irradi
autolog
monocyt
untreat
prepuls
h
peptid
pool
overlap
cover
entir
sequenc
variabl
region
nzm
heavi
light
chain
nzm
peptid
pool
per
peptid
produc
lab
day
cell
stain
antibodi
bd
bioscienc
clone
cat
icospacif
blue
biolegend
clone
cat
prolifer
activ
cell
exvivo
stimul
cultur
sort
cfse
low
ico
clone
limit
dilut
cell
clone
reactiv
determin
stimul
irradi
autolog
monocyt
b
cell
untreat
prepuls
h
nzm
peptid
pool
per
peptid
experi
recombin
nzm
cell
clone
prolifer
measur
day
h
incub
h
thymidin
perkin
elmer
posit
cell
clone
select
base
cutoff
valu
count
per
minut
cpm
antigen
antigenpres
cell
apc
ii
stimul
index
cpm
antigen
apc
cpm
apc
determin
mhc
restrict
stimul
assay
perform
absenc
presenc
block
antimhcii
monoclon
antibodi
produc
hous
hybridoma
cell
line
antihladr
clone
atcc
cat
antihladq
clone
antihladp
clone
epitop
map
perform
stimul
cell
clone
irradi
ebvimmort
bcell
ebvb
clone
untreat
prepuls
h
individu
peptid
overlap
cover
entir
sequenc
variabl
region
nzm
heavi
light
chain
per
peptid
sequenc
analysi
rearrang
tcr
gene
nzmspecif
cell
clone
perform
previous
describ
briefli
cdna
individu
cell
clone
obtain
revers
transcript
total
rna
cell
per
reaction
rearrang
tcr
gene
pcr
amplifi
use
forward
primer
pool
target
gene
revers
primer
pair
constant
region
sequenc
amplif
assess
agaros
gel
electrophoresi
success
amplifi
fragment
sequenc
sanger
method
tcr
sequenc
annot
carri
use
imgtvquest
algorithm
hla
genotyp
patient
determin
revers
sequencespecif
oligonucleotid
probe
nzmspecif
ebvb
clone
isol
two
patient
puls
overnight
nzm
cellular
densiti
small
aliquot
elut
fraction
analyz
sdspage
evalu
yield
puriti
mhcii
complex
seppak
water
milford
cartridg
use
separ
peptid
mhcii
subunit
cartridg
prewash
acetonitril
acn
formic
acid
follow
trifluoroacet
acid
tfa
subsequ
load
time
fraction
elut
immunoaffin
column
load
cartridg
wash
tfa
peptid
separ
hydrophob
mhcii
chain
elut
acn
tfa
peptid
purifi
use
silica
column
tip
harvard
apparatu
holliston
elut
acn
tfa
final
peptid
concentr
vacuum
centrifug
resuspend
acn
tfa
formic
acid
ms
analysi
mhcii
peptid
separ
easynlc
hplc
system
coupl
onlin
q
exact
mass
hf
spectromet
via
nanoelectrospray
sourc
thermo
fisher
scientif
peptid
load
buffer
formic
acid
inhous
pack
column
inner
diamet
cm
length
particl
dr
maisch
gmbh
elut
nonlinear
min
gradient
buffer
b
acn
formic
acid
flow
rate
nlmin
column
temperatur
q
exact
oper
data
depend
mode
survey
scan
rang
mz
resolut
mz
abund
isotop
pattern
charg
isol
th
wide
isol
window
subject
higherenergi
ctrap
dissoci
hcd
fragment
normal
collis
energi
fragment
spectra
acquir
resolut
mz
dynam
exclus
sequenc
peptid
set
reduc
number
repeat
sequenc
threshold
ion
inject
time
ion
target
valu
set
ms
survey
scan
ms
msm
scan
respect
data
acquir
use
xcalibur
softwar
thermo
scientif
maxquant
softwar
use
analyz
mass
spectrometri
raw
file
msm
spectra
search
fulllength
nzm
heavi
light
chain
sequenc
human
uniprot
fasta
databas
common
contamin
databas
entri
andromeda
search
engin
ntermin
acetyl
methionin
oxid
set
variabl
modif
fix
modif
select
enzym
specif
set
unspecif
minimum
peptid
length
amino
acid
fals
discoveri
rate
fdr
requir
peptid
peptid
identif
perform
allow
precursor
mass
deviat
ppm
allow
fragment
mass
deviat
ppm
match
run
option
disabl
graphpad
prism
softwar
use
perform
statist
analys
ngml
ngml
valu
calcul
everi
antibodi
test
differ
elisa
assay
inhibit
nzm
bind
assay
respect
nonlinear
regress
analysi
use
graphpad
prism
softwar
twotail
spearman
correl
perform
correl
nzm
neutral
associ
constant
k
dissoci
constant
k
n
indic
number
antibodi
test
pair
graphpad
prism
softwar
comput
approxim
p
valu
nonparametr
correl
extrem
signific
p
valu
indic
p
